Historical record - last NADAC publication: 10/18/2023

Product Information

DEXTROAMP-AMPHETAM 7.5 MG TAB is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.6705 per EA under NDC 70010011201. Its NADAC has been published 14 times since Aug 9, 2023.

The High Outlier badge above means this manufacturer's average price in the Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

High Outlier
DEA Schedule CII

Strength

1.875; 1.875; 1.875; 1.875 mg/1; mg/1; mg/1; mg/1

NDC

70010011201

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

10/18/2023

Approval Type

Generic (ANDA)

FDA Application

ANDA215771

On Market Since

3/28/2023

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHETAM 7.5 MG TAB has been published 14 times since Aug 9, 2023, and over the history we have for it it has risen 20.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6705 per EA
All-time high$0.6705 (Nov 8, 2023)
All-time low$0.5515 (Aug 23, 2023)
Median price$0.5515
Average price$0.5860
Largest weekly change+21.6% (Oct 18, 2023)
Weeks tracked14
Tracking sinceAug 9, 2023

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

+20.9%

Generic Alternatives

The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 61% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHETAM 7.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAM 7.5 MG TAB, manufactured by Granules Pharmaceuticals Inc., is $0.6705 per EA (NDC 70010011201), effective Nov 8, 2023.

How has the price of DEXTROAMP-AMPHETAM 7.5 MG TAB changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAM 7.5 MG TAB has risen 20.9%. It has been tracked across 14 weekly CMS publications since Aug 9, 2023.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAM 7.5 MG TAB?

Since Aug 9, 2023, the NADAC for DEXTROAMP-AMPHETAM 7.5 MG TAB has ranged from a low of $0.5515 (Aug 23, 2023) to a high of $0.6705 (Nov 8, 2023), with a median of $0.5515 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHETAM 7.5 MG TAB?

Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DEXTROAMP-AMPHETAM 7.5 MG TAB, is $0.2629 per EA — about 61% below DEXTROAMP-AMPHETAM 7.5 MG TAB.

Who manufactures DEXTROAMP-AMPHETAM 7.5 MG TAB?

DEXTROAMP-AMPHETAM 7.5 MG TAB (NDC 70010011201) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.